On Criticism of ACS and C&EN

Why don’t scientists complain to the source when invited to do so? Today, we discuss a call from C&EN News Editor-in-Chief, Rudy Baum, actively soliciting criticism of the ACS magazine – a post that in two weeks has netted a whopping five comments.  It’s not blogophobia – chemists seem willing to comment at In the Pipeline (18 Apr, 11 Aug, 20 Aug) and Chemjobber (8 Sept). Baum routinely and freely publishes...

Read More
Flurry of FDA action against aromatase inhibitor supplements
Sep27

Flurry of FDA action against aromatase inhibitor supplements

If you’ve ever met me, you’ll know that I’m not a bodybuilder. That’s why I was taken aback earlier this year when I learned that men are taking aromatase inhibitors – and not for breast cancer. This education came to me when I was asked by a network news program to comment on a litany of drugs and supplements found in the possession of self-proclaimed guru James Arthur Ray following the Sedona sweat...

Read More
The nine lives of grandmothers
Sep22

The nine lives of grandmothers

I was following up on the writing of Don Troop at The Chronicle of Higher Education after he came by to comment on one of our posts that cited his work. Don had an excellent, frontpage article a couple of weeks ago interviewing scholars who cite running and other physical activity and exhaustion with creativity. (Here was our post.) Yesterday, Don put up a post at his Tweed blog on the “lighter side of academe.” The title?...

Read More
Joint ACS/AACR meeting on biological chemistry of inflammation in cancer
Sep21

Joint ACS/AACR meeting on biological chemistry of inflammation in cancer

A meeting notice arrived in my e-mail yesterday that is particularly timely during my first month as a CENtral Science blogger. The Chemistry in Cancer Research (CICR) working group of my primary scientific society, the American Association for Cancer Research (AACR), will be hosting a joint meeting with ACS in San Diego in early 2011: A joint meeting between the AACR and the American Chemical Society Chemistry in Cancer Research: The...

Read More

Bleachgate: UK and Kenyan press raising awareness of Miracle Mineral Solution

In July, the US FDA issued a warning to consumers about a dietary supplement product being sold worldwide under the name Miracle Mineral Solution or Supplement (MMS). Marketed as a cure for everything from HIV/AIDS and cancer to malaria and tuberculosis, the product is 28 percent sodium chlorite.  The consumer is instructed to mix the solution with a citrus juice, generating chlorine dioxide, and is encouraged to take 30 drops or more...

Read More